Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1998 1
1999 2
2000 1
2002 2
2003 2
2004 1
2006 2
2007 1
2009 2
2010 1
2011 2
2012 8
2013 5
2014 2
2015 6
2016 11
2017 10
2018 11
2019 6
2020 15
2021 11
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

96 results
Results by year
Filters applied: . Clear all
Page 1
In Reply.
Brandi G, Deserti M, Vasuri F, Farioli A, Degiovanni A, Palloni A, Frega G, Barbera MA, de Lorenzo S, Garajova I, Di Marco M, Pinna AD, Cescon M, Cucchetti A, Ercolani G, D'Errico-Grigioni A, Pantaleo MA, Biasco G, Tavolari S. Brandi G, et al. Among authors: de lorenzo s. Oncologist. 2016 Dec;21(12):e5-e6. doi: 10.1634/theoncologist.2016-0286. Epub 2016 Nov 2. Oncologist. 2016. PMID: 27807301 Free PMC article.
Adjuvant treatment in biliary tract cancer.
Palloni A, Frega G, De Lorenzo S, Rizzo A, Abbati F, Deserti M, Tavolari S, Brandi G. Palloni A, et al. Among authors: de lorenzo s. Transl Cancer Res. 2019 Apr;8(Suppl 3):S289-S296. doi: 10.21037/tcr.2018.08.17. Transl Cancer Res. 2019. PMID: 35117108 Free PMC article. Review.
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma.
Tovoli F, Dadduzio V, De Lorenzo S, Rimassa L, Masi G, Iavarone M, Marra F, Garajova I, Brizzi MP, Daniele B, Trevisani F, Messina C, Di Clemente F, Pini S, Cabibbo G, Granito A, Rizzato MD, Zagonel V, Brandi G, Pressiani T, Federico P, Vivaldi C, Bergna I, Campani C, Piscaglia F. Tovoli F, et al. Among authors: de lorenzo s. Liver Cancer. 2021 Jul;10(4):370-379. doi: 10.1159/000515551. Epub 2021 Jun 15. Liver Cancer. 2021. PMID: 34414124 Free PMC article.
Regorafenib for the treatment of hepatocellular carcinoma.
Tovoli F, Granito A, De Lorenzo S, Bolondi L. Tovoli F, et al. Among authors: de lorenzo s. Drugs Today (Barc). 2018 Jan;54(1):5-13. doi: 10.1358/dot.2018.54.1.2736667. Drugs Today (Barc). 2018. PMID: 29569657 Review.
Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow.
Rizzo A, Ricci AD, Tober N, Nigro MC, Mosca M, Palloni A, Abbati F, Frega G, DE Lorenzo S, Tavolari S, Brandi G. Rizzo A, et al. Among authors: de lorenzo s. Anticancer Res. 2020 Jun;40(6):3013-3030. doi: 10.21873/anticanres.14282. Anticancer Res. 2020. PMID: 32487595 Review.
Microbiota, NASH, HCC and the potential role of probiotics.
Brandi G, De Lorenzo S, Candela M, Pantaleo MA, Bellentani S, Tovoli F, Saccoccio G, Biasco G. Brandi G, et al. Among authors: de lorenzo s. Carcinogenesis. 2017 Mar 1;38(3):231-240. doi: 10.1093/carcin/bgx007. Carcinogenesis. 2017. PMID: 28426878 Review.
96 results